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GPR179 Is Required for Depolarizing Bipolar Cell
Function and Is Mutated in Autosomal-Recessive
Complete Congenital Stationary Night Blindness
Neal S. Peachey,1,2,3 Thomas A. Ray,4 Ralph Florijn,5 Lucy B. Rowe,6 Trijntje Sjoerdsma,7
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Complete congenital stationary night blindness (cCSNB) is a clinically and genetically heterogeneous group of retinal disorders charac-
terized by nonprogressive impairment of night vision, absence of the electroretinogram (ERG) b-wave, and variable degrees of involve-
ment of other visual functions. We report here that mutations in GPR179, encoding an orphan G protein receptor, underlie a form of
autosomal-recessive cCSNB. The Gpr179nob5/nob5 mouse model was initially discovered by the absence of the ERG b-wave, a component
that reflects depolarizing bipolar cell (DBC) function. We performed genetic mapping, followed by next-generation sequencing of the
critical region and detected a large transposon-like DNA insertion in Gpr179. The involvement of GPR179 in DBC function was
confirmed in zebrafish and humans. Functional knockdown of gpr179 in zebrafish led to a marked reduction in the amplitude of the
ERG b-wave. Candidate gene analysis of GPR179 in DNA extracted from patients with cCSNB identified GPR179-inactivating mutations
in two patients. We developed an antibody against mouse GPR179, which robustly labeled DBC dendritic terminals in wild-type mice.
This labeling colocalized with the expression of GRM6 and was absent in Gpr179nob5/nob5 mutant mice. Our results demonstrate that
GPR179 plays a critical role in DBC signal transduction and expands our understanding of the mechanisms that mediate normal rod
vision.Congenital stationary night blindness (CSNB) is a severe
disability that impairs night vision. Complete CSNB
(cCSNB) is a genetically heterogeneous form of the
disorder that is caused by mutations in genes that are
required for signal transduction through retinal depolariz-
ing bipolar cells (DBCs).1–8 The function of photoreceptors
and DBCs can be assessed noninvasively with the electro-
retinogram (ERG), and their light-induced activities are re-
flected in the a-wave and b-wave, respectively.9 Individuals
with cCSNB and animal models of the disorder have an
ERG waveform that lacks the b-wave because of a failure
to transmit the photoreceptor signal through the DBCs.
Depolarization of the DBCs is initiated by a metabotropic
glutamate receptor-mediated (GRM6)10 modulation of
a transient receptor potential melastatin 1 cation channel
(TRPM1).11–13 This G protein signal transduction cascade
utilizes Gao1,14 Gb5,15 and depends on the auxiliary
protein nyctalopin.16,17 Mutations in GRM6 (MIM
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The Americawhich encodes nyctalopin, all can cause cCSNB in
humans.1–8 Mice with mutations in Grm6, Trpm1, Gna0,
and Gnb5 or Nyx also have a no b-wave (nob) ERG pheno-
type.10–16,18–20 In this report, we define a critical role for
GPR179, a previously uncharacterized orphan G protein
receptor, in the DBC signal transduction cascade and in
human cCSNB. Specifically, mutations in GPR179 in hu-
mans are responsible for a form of cCSNB. Consistent
with this result, nob5 mice have a mutation in Gpr179
(Gpr179nob5/nob5) and a nob ERG phenotype. Finally, zebra-
fish, whose gpr179 expression is knocked down via mor-
pholino injection, have a reduced ERG b-wave amplitude.
The nob5 mouse arose as a spontaneous mutation in
a colony of C3H mice and was identified via ERG when
this line was crossed to a line of C3H mice lacking the
rd1 mutation (C3H-fþ/þ). To identify the causative muta-
tion, we crossed affected nob5 mice to wild-type (WT)
C57BL/6J mice and the resulting F1 mice were intercrossed
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Figure 1. Transposable Element Disrupts
Gpr179 Expression in nob5 Mouse
(A) PCR fragments from Gpr179nob5/nob5 (lane 1),
Gpr179nob5/þ (lane 2), and WT C3H (lane 3). The
insertion is ~6.5 kb.
(B) Schematic exon map of Gpr179 indicating
location of nob5 insertion mutation. The arrows
indicate location of PCR primers used in (A).
(C) Quantitative PCR of Gpr179 cDNA generated
from mRNA isolated from retinas of WT and
Gpr179nob5/nob5 mice. Expression of Gpr179 was
normalized to that of 18S RNA and is relative to
the Gpr179 expression inWT. The error bars indi-
cate mean 5 standard deviation for three mice.
Gpr179 expression in Gpr179nob5/nob5 retina is
significantly reduced (p < 0.0005). All animal
studies were approved by the local institutional
animal care and use committees and conformed
to all regulatory standards.progeny homozygous for the nob5 locus by ERG and used
them to map the phenotype by using a genome-wide
screen with 103 simple sequence length polymorphic
markers distributed throughout the genome.21 Initial
mapping localized the gene to chromosome 11. Subse-
quently, > 600 additional informative meioses refined
the map location of the nob5 locus to between D11Mit54
and D11Mit67. This 1.3 Mb region contains over 90 genes,
none of which were known to be involved in DBC signal
transduction or had been identified in molecular analyses
of enriched pools of DBCs.22–24 To identify the mutation
underlying the nob5 phenotype we used genome capture
and high-throughput sequencing. Comparison of the
sequence encompassing the critical region in nob5/nob5
and WT C3H mice revealed the presence of an insertion
in intron 1 of Gpr179 (Figure 1A). The next-generation
sequence data provided only 10 bp of sequence on either
side of the insertion, but these data suggested the insertion
was a transposable element. To examine this directly, we
used PCR to amplify the insertion and its flanking intronic
DNA. This revealed the presence of the predicted 1.3 kb
fragment inWTmice and a 7.8 kb fragment in homozygous
affected littermates, indicating the insertion is ~6.5 kb
(Figure 1A). Both bands were seen in heterozygotes. Hence-
forth, the mutant nob5 allele will be referred to as
Gpr179nob5. Sequence analyses of the ends of the insertion
indicated it was an endogenous retroviral element of the
ERV2 class (Figure 1B). To evaluate the impact of this inser-
tion on Gpr179 expression, we used a quantitative intron-
spanning Taqman RT-PCR assay to determine Gpr179
mRNA levels of WT and Gpr179nob5/nob5 retinas
(Figure 1C). The expression of mRNA representing Gpr179
in the Gpr179nob5/nob5 retina was decreased more than
800-fold compared to the expression of mRNA in the WT
retina. These data indicate that the Gpr179nob5/nob5 pheno-
type is caused by a large insertion mutation in intron 1 of
Gpr179; this insertion dramatically reduces gene expres-
sion and probably represents a null allele.
A series of dark-adapted ERGs obtained from representa-
tive WT, Gpr179nob5/þ, and Gpr179nob5/nob5 mice are shown332 The American Journal of Human Genetics 90, 331–339, Februaryin (Figure 2A). Throughout the stimulus range examined,
WT ERGs are dominated by a positive polarity b-wave,
which increases in amplitude with increasing flash lumi-
nance and reflects the light-induced activity of DBCs.25
At higher flash luminance, the b-wave was preceded by
a negative polarity a-wave, reflecting the light-induced
closure of cation channels along rod photoreceptor outer
segments.26 ERG responses in heterozygous Gpr179nob5/þ
mice resembled the responses of WT mice, consistent
with autosomal-recessive inheritance. In contrast,
whereas large a-waves are obtained from homozygous
Gpr179nob5/nob5 mice, these responses lack the b-wave
component, revealing slow PIII, an ERG component
generated by the radial Mu¨ller glial cells.27 Summary plots
for the major components of the dark-adapted ERGs are
shown in Figure 2B. ERG a-wave amplitudes were compa-
rable across the three genotypes and the b-waves of
Gpr179nob5/þ and WT mice were indistinguishable. The
b-wave component is absent in Gpr179nob5/nob5 mice,
and therefore, these data are not plotted. This ERG
phenotype, in which the b-wave is absent while the
a-wave is preserved, indicates that rod phototransduction
is unaffected in Gpr179nob5/nob5 mice, whereas synaptic
transmission between photoreceptors and DBCs, or DBC
activity itself, is grossly abnormal.28 Light-adapted ERGs
obtained from representative WT, Gpr179nob5/þ, and
Gpr179nob5/nob5 mice are shown in Figure 2C. In WT
mice, the cone ERG was dominated by the positive
polarity b-wave and higher frequency oscillatory poten-
tials, which reflect activity through the DBC pathway.29
In contrast, cone ERGs of Gpr179nob5/nob5 mice are electro-
negative. Summary plots for cone ERGs recorded from all
three genotypes are shown in Figure 2D. When cone ERG
amplitude is measured from the negative trough to the
following positive peak, the Gpr179nob5/nob5 response is
reduced in amplitude, whereas those from WT and
Gpr179nob5/þ heterozygotes are comparable. The
Gpr179nob5/nob5 ERG phenotype is essentially indistin-
guishable from those of mouse mutants for other proteins
involved in DBC signal transduction, including10, 2012
Figure2. ERGPhenotypeofGpr179nob5/nob5
Mice
ERGs were recorded from mice anesthe-
tized with ketamine (80 mg/kg) and xyla-
zine (16 mg/kg) after overnight dark
adaptation via a published procedure.16
(A) Dark-adapted ERG series obtained from
representative WT (left), Gpr179nob5/þ
(middle), and Gpr179nob5/nob5 (right) litter-
mates at 6 months of age. The scale bars
indicates 100 ms and 500 mV. Values to
the left of each row of waveforms indicate
flash luminance in log cd s/m2. (B) Lumi-
nance-response functions for the major
components of the dark-adapted ERG.
The b-wave component is absent in
Gpr179nob5/nob5 mice and therefore these
data are not plotted. (C) Cone-mediated
ERG series obtained from WT (left),
Gpr179nob5/þ (middle), and Gpr179nob5/nob5
(right) littermates at 6 months of age. Scale
bar indicates 100ms and 100 mV. (D) Lumi-
nance-response functions for the cone
ERG b-wave. Values to the left of each
row of waveforms indicate flash lumi-
nance in log cd s/m2.GRM6,10,19,20 TRPM1,11–13 and NYX,16,18 a protein
required for correct localization of TRPM1 channels in
DBC dendrites.17
GPR179 encodes a predicted orphan G protein-linked
receptor that has not been previously characterized in
any cell or tissue. The nob5 phenotype predicts that the
GPR179 gene product is required for DBC function and
therefore should be present in DBCs. Because DBCs receive
input from photoreceptors via ribbon synapses in the
outer plexiform layer (OPL), we initially characterized
gross retinal morphology and OPL ultrastructure of the
Gpr179nob5/nob5 retina. However, all cellular and synaptic
layers appeared normal in the Gpr179nob5/nob5 retina
(Figure 3A). Furthermore, Gpr179nob5/nob5 ribbon synapses
are indistinguishable from WT (Figure 3B). A normal
retinal morphology is typical of all other mouse models
of cCSNB.10,12,13,18,30
To examine the cellular localization of GPR179 in the
mouse retina, we developed a polyclonal sheep antibody
to a peptide (KVQEETPGEDLDRPVLQKR) located within
the amino terminal extracellular domain. Retinal cryosec-
tions from Gpr179nob5/þ and Gpr179nob5/nob5 littermates
were reacted with our antibody to GPR179 and an anti-
body against PKCa to label rod DBCs. In Gpr179nob5/þ
retina, PKCa labeled the entire rod DBC (Figures 3C and
3E), whereas the GPR179 antibody produced a punc-
tuate-labeling pattern (Figures 3D and 3E), which corre-
sponds to the location of the OPL. In the Gpr179nob5/nob5
retina, labeling for PKCa (Figures 3F and 3H) is comparable
to Gpr179nob5/þ and labeling for GPR179 is absent (Figures
3G and 3H), consistent with decreased Gpr179 mRNA
expression inGpr179nob5/nob5 retinas (Figure 1C). The punc-
tuate-labeling pattern of GPR179 in the OPL is typical ofThe Americaproteins that are localized to the dendritic tips of DBCs,
including GRM6, TRPM1 and NYX.12,16 To confirm this
localization, we double-labeled retinal sections with anti-
bodies to GPR179 (Figure 3I) and GRM6 (Figure 3J) The
punctate labeling for GPR179 colocalizes with GRM6
(Figure 3L), the glutamate receptor known to mediate
signaling in DBCs. These data show that GPR179 is ex-
pressed on the dendritic terminals of DBCs. GPR179 is
not expressed elsewhere in the retina (data not shown).
The combined ERG, genetic and immunohistochemical
data argue strongly that the Gpr179nob5/nob5 mouse pheno-
type is caused by the insertion and results in a functionally
null allele of GPR179.
To directly determine whether reduced GPR179 expres-
sion could recapitulate the reduced b-wave phenotype,
we used morpholino knockdown in zebrafish, which
have a single copy of gpr179 in their genome. We injected
1 cell stage zebrafish embryos withmorpholinos (MOs) tar-
geted against the Gpr179 translation start site (MO-Gpr179
50-GCCCATACTTTTAGCAACTGCTTCT-30), and recorded
ERGs at 4-6 days post fertilization. As comparisons, MOs
against either the nyx translation start site (MO-Nyx
50-GATGAAACACATCACTGGCTTC-30)31 or control (C-MO
50-CCTCTTACCTCAGTTACAATTTATA-30) were injected.
Embryos injected with MO-Gpr179 had a significantly
reduced ERG b-wave amplitude, similar to embryos in-
jected with MO-Nyx (positive control) (Figures 4A and
4B). The b-wave was unaffected following injection of
the control MO (Figure 4B). The b-wave/a-wave ratio
decreased from 3.79 5 0.46 (n ¼ 4) in control to 0.75 5
0.11 (n ¼ 7) in Gpr179-MO (p ¼ 0.005). These results indi-
cate that gpr179 expression is required for normal DBC
function in zebrafish.n Journal of Human Genetics 90, 331–339, February 10, 2012 333
Figure 3. Anatomical Phenotype of Gpr179nob5/nob5 Retina
(A) Retinal cross-sections obtained from Gpr179nob5/þ and Gpr179nob5/nob5mouse retinas fixed with 2.5% glutaraldehyde/2% paraformal-
dehyde and prepared according to published procedures.35
(B) Electron micrographs of ribbon structures in Gpr179nob5/þ and Gpr179nob5/nob5 mouse retinas prepared according to published proce-
dures.
(C–K) Confocal immunohistochemistry of retinas fixed with 4% paraformaldehyde for 15 min and prepared according to published
procedures.16 The scale bar indicates 5 mm. (C–E) Gpr179nob5/þ retina labeled with antibodies against (C) PKCa, (D) GPR179, and (E)
merge of (C) and (D). (F–H) Gpr179nob5/nob5 retina labeled with antibodies against (F) PKCa, (G) GPR179, and (H) merge of (F) and
(G). (I–K) Gpr179nob5/þ retina labeled with antibodies for (I) GPR179, (J) GRM6, and (K) merge of I–J. The following antibodies were
used: GPR179; affinity purified polyclonal sheep anti-GPR179 peptide (KVQEETPGEDLDRPVLQKR), 1:1,000; mouse monoclonal
anti-ctbp2/Ribeye, 1:1,000 (BD Biosciences); guinea pig anti-GRM6, 1:1000 (see Koike et al.12); rabbit anti-PKCa (1:1,000, Sigma). The
following secondary antibodies were used: Alexa-488 donkey anti-sheep, Alexa-555 goat anti-rabbit, and Alexa-633 goat anti-guinea
pig (all at 1:1,000; Invitrogen).Mutations in NYX, GRM6 or TRPM1 have been identi-
fied in patients with cCSNB.1–8 However, a small number
of individuals with cCSNB did not bear mutations in any
of these genes.8 To evaluate the potential involvement of
GPR179 in cCSNB patients lacking DBC function, we
sequenced the 11 exons and flanking splice sites of the
human gene in 44 patients (see Table 1 for primers). All
human studies were undertaken with the approval of
the appropriate institutional review board. We identified
two probands with inactivating mutations in the
GPR179 gene. Proband 1 had no family history of night334 The American Journal of Human Genetics 90, 331–339, Februaryblindness or consanguinity and was 10 years old at the
time of diagnosis. He presented with 20/70 best corrected
visual acuities, mild myopic refractive error, congenital
nystagmus, a history of early onset nightblindness,
a normal retinal appearance and full Goldmann visual
fields. ERGs obtained under ISCEV standard conditions
from proband 1 are shown in Figure 5A. Under dark-
adapted conditions (upper traces), the ERG b-wave re-
corded to a low luminance stimulus was markedly
reduced in amplitude, whereas the ERG obtained to
a high flash luminance had a robust a-wave without the10, 2012
Figure 4. GPR179 Knockdown in Zebrafish Decreases ERG
b-Wave
InjectedMOs (Gene Tools) were designed against the gpr179 trans-
lation site (MO 50-GCCCATACTTTTAGCAACTGCTTCT-30), which
occurs as a single copy in the zebrafish genome, or the nyx trans-
lation site (MO 50-GATGAAACACATCACTGGCTTC-30) or were
a standard control (MO 50-CCTCTTACCTCAGTTACAATTTATA-30).
In each case, 30 ng of MO was injected into the chorions of one-
cell-stage zebrafish embryos. ERGs were recorded from larvae at
4–6 days post fertilization with a 1 s stimulus after 30 min of
dark adaption, as previously described.36
(A) ERGs from embryos injected with control (left column) or MO-
gpr179 (right column) MOs and tested at four flash intensities.
Flash intensity at 0 log is 9.3 W/m2. Neutral density (ND) filters
reduced the intensity by the indicated amount in log units. The
b-wave amplitudes obtained from MO-gpr179 injected embryos
were strongly reduced at all intensities. The b-wave/a-wave ratio
decreased from 3.79 5 0.46 (n ¼ 4) in control to 0.75 5 0.11
(n ¼ 7) in MO-gpr179 (p ¼ 0.005), showing that a specific knock-
down of gpr179 reduces DBC function.
(B) The magnitude of b-wave reduction for MO-gpr179 and
MO-nyx were comparable. Injections of MO-control did not affect
the ERG (data not shown).subsequent b-wave seen in controls (middle traces). Under
light-adapted conditions (lower pair of traces), the ERG
waveform showed a square a-wave but retained a late
positive ERG component. ERGs of proband 2 showed
a similar selective absence of the dark-adapted b-wave
and a square light-adapted ERG a-wave (data not shown).
These ERG abnormalities have been uniquely associatedThe Americawith human cases of DBC dysfunction32–34 and readily
distinguish cCSNB from other retinal disorders with
a reduced b-wave, such as incomplete CSNB (MIM
300071 and 610427).33
Proband 1 was a compound heterozygote for two frame-
shift mutations in GPR179, c.187delC and c.984delC
(NM_001004334.2) resulting in predicted protein trunca-
tions p.Leu63Serfs*12 and p.Ser329Leufs*4, respectively
(Figure 5B). The premature chain termination is expected
to result in functional null alleles. The probands’ unaf-
fected parents were each heterozygous for one of themuta-
tions (Figure 5B).
Proband 2 was 20 years old at the time of diagnosis. She
is of Norwegian descent and presented with rotatory
nystagmus, a very unusual blond fundus, and congenital
nightblindness and was able to see 20/30 with a
12.00 D prescription. Although not known to be related,
proband 2 also carried the c.984delC frameshift mutation
identified in proband 1, suggesting that this might be
a founder mutation. Proband 2 carried a second mutation,
c.659A>G, that would result in missense mutation,
p.Tyr220Cys. (Figure 5C). The three variants in probands
1 and 2 were not present in 210 healthy control chromo-
somes. Two out of three Alamut analyses, which predict
mutation impact on function, classified the p.Tyr220Cys
as potentially pathogenic. Moreover, by introducing
a new cysteine into the GRP179 protein, the mutation is
likely to impact its structure. The functional importance
of Tyr220 is supported by its conservation across species
ranging from human to Tetraodon (Figure 5D). DNA of
familymembers of proband 2 was not available for segrega-
tion analysis.
The combined data indicate that GPR179 is required for
DBC signal transduction and that mutations that disrupt
the function of GPR179 cause a recessive form of cCSNB.
Although Gpr179nob5/nob5 mice lack expression of GPR179,
we have not detected any anatomical defect in the retina,
and the mice have no apparent health problem. Similarly,
the two human patients we have identified with cCSNB
and mutations in GPR179 have no other known health
problems. Given the ERG phenotype in mice, zebrafish,
and humans, as well as the colocalization of GPR179
with GRM6, we postulate that GPR179 plays a critical
role in DBC signal transduction, possibly by forming
heterodimers with GRM6. Future studies will be required
to define the specific role of GPR179 in this process.
The availability of the Gpr179nob5/nob5 mouse model
will be an important tool with which to address this
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Table 1. PCR Primers Used to Generate Products for Sequence Analysis
Name Forward Primer (50/30) Reverse Primer (50/30) Amplicon Size (bp)
GPR179-EXON1_1 GACTGCAGCCAGCCTCTG GCATGTTGAGAAAATTGGCG 402
GPR179-EXON1_2 AGATGCCCAGCAGCTATCAC TCAACACTCGCTTCTTCAGG 410
GPR179-EXON1_3 ACCTTTAACCCTCCACCAGG GGACCTGTACTTCCTTCCCC 410
GPR179-EXON2 AAAGTGCCATAATTCCGAGC GAGATGCTGGGGTAGCTTTG 330
GPR179-EXON3 GACCCAAGTCCCATGGATAG GTACCCTCCCAACCATCCTC 261
GPR179-EXON4 GGCTGTGGTGACTATCAGGG TAGTCTCAGGCCTCCAGTTG 386
GPR179-EXON5 ACAGGGTGAAGCCTTAGCTC GTGCCAGGTTTTGGCTATG 241
GPR179-EXON6 TGGTGATGGCTCTATTGCAG ATGAGTGAGCTGGGGTGG 284
GPR179-EXON7 CAGCAATGGACAGAGACCAG CCAGAACAAGAGGAACCCTG 401
GPR179-EXON8 TCTTTCAGAGAAAGGGGTGG GTAGCAGTGTTGCCAGGATG 313
GPR179-EXON9 CTAAGCGTATCAGGGTTGGG CTCCACAGTGGCCCTGAC 274
GPR179-EXON10 TGAGTGCAGGAGTGGACAAG GACTTGCAGTGGCACATAGC 311
GPR179-EXON11-1 AAGGGTGGAGGAACAGACAG CGCTGGCTGACCTGAAG 497
GPR179-EXON11-2 GACCCGCCTCTTCTTGACTC TAGAAACCTGGTGCCTGATG 472
GPR179-EXON11-3 AGGCCATCAGCCAGGAG GCCCTGCTTTTCTCTACTGC 473
GPR179-EXON11-4 CAGCCAAGCAAGAAAATGTG TCTGTTGGTTCTGGAGGGAC 471
GPR179-EXON11-5 CGTTCTCGGAGCACCTACAG GCTGACGCGTTTCTGATTC 481
GPR179-EXON11-6 ATCAAAAGAAACCCCTGTCG TCAGGGGTATGAGCTTCTGG 480
GPR179-EXON11-7 CTGGGAGACGAGTGAAGGAG AAGTCTCCTCCCGGTTTCTG 474
GPR179-EXON11-8 AGTGAAGGAGGCGAGGATG TCTCCCTGGGACAAACTGAC 463
GPR179-EXON11-9 AATGCTGAGTCTGGGGACAG GTCTTGAGGACGTGGTTGTG 529
GPR179-EXON11-10 TGGAAAATCGGAAATCGAAG ACCTGGATGCTGAGAACAGG 460
GPR179-EXON11-11 CCCAGGGAGAGAGCTGTTAC GCTGCTGGGCAAGTCTGAG 474
GPR179-EXON11-12 GCCTGTTCTCAGCATCCAG TGGGTTATGTGTTCTGGGAAG 482
GPR179-EXON11-13 GAGTAGTGAAGTGGCAGAGGG CTGAACTGGCACACCTTTTG 487
GPR179-EXON11-14 AATCTGACAGCAGTGCCAAG AGGAACATCTCTCCTTGCCC 445
GPR179-EXON11-15 CTGTGGGAAGTGGTAGAGGC TTTTCAGGAGCTGTGGGG 473
GPR179-EXON11-16 AGGGTACCATGGCAGACATC TTCAGCTCTTTGGGAACACC 486(R21EY021852 to N.S.P. and R.G.G.; R01EY12354 to R.G.G.;
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Figure 5. GPR179 Mutations Are Present in Two Probands with Autosomal-Recessive cCSNB
(A) ERGs obtained from a control subject and proband 1 for a standard series of stimulus conditions that allow rod- and cone-mediated
responses to be evaluated. For proband 1 (patient 06-130), the two records indicate ERGs obtained from the two eyes. Under dark-adapt-
ed conditions, ERGs obtained from the proband had markedly reduced b-waves. Under light-adapted conditions (30 cd/m2), the cone
ERG had a squared a-wave (arrow). Values indicate flash luminance in log cd s/m2.
(B and C) GPR179 (accession number NM_001004334.2) exons were sequenced from DNA samples isolated from 44 patients with
cCSNB. Chromatograms containing the mutant sequences found in probands 1 (B) and 2 (C). In addition to the chromatogram,
each subsection shows the mutation, the predicted impact on the amino acid sequence, and the segregation pattern. The pedigree
for proband 1 shows that he inherited one mutant GPR179 allele from each parent (c.187delC and c.984delC), who had normal vision
(data not shown). The parents of proband 2 were not available for analyses.
(D) Comparison of the region of GPR179 containing the amino acid substitution (p.Tyr220Cys) identified in proband 2 across phyla.
With the exception ofDrosophila melanogaster, Tyr220 is conserved for every species for which data were available. In general, this region
of the protein is highly conserved (the shade of blue indicates the amount of conservation; dark blue indicates the most conserved). The
study followed the tenets of the Declaration of Helsinki and was approved by the ethics committee of the Academic Medical Centre,
Amsterdam. All participants provided signed informed consent for participation in the study.References
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